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Background: The STS risk prediction score is applicable only for patients undergoing midline sternotomy. Hence, we sought to develop a simple 
risk score for prediction of Society of Thoracic Surgeons (STS) composite endpoint for patients undergoing minimally invasive valve surgery (MIVS).
methods: A total of 960 patients who underwent MIVS were randomly assigned to a development and validation dataset (480 patients each). 
Multivariable logistic regression was then used to identify independent predictors with a p-value of <0.1. Based on the odds ratios, five identified 
variables (age>55 years, GFR<60 cc/min, history of cerebrovascular accident, heart failure in the preceding two weeks, left ventricular ejection 
fraction <55%) were assigned a weighted integer; the sum of the integers was a total risk score for each patient.
results: The rate of composite endpoint in the development cohort was 21% (14.3% for low [≤7], 19.5% for intermediate [8-13], and 54% for high 
[≥14] risk score). The rate of composite endpoint increased exponentially with the increasing risk score (Cochrane Armitage chi-square, p<0.0001). 
In the 480 patients of the validation dataset, the model demonstrated a good discriminatory power (c-statistic = 0.71); the increasing risk score was 
strongly associated with the occurrence of composite endpoint (see table).
conclusion: The risk of STS composite endpoint for patients undergoing MIVS can be easily assessed by readily available baseline clinical 
characteristics of patients.
 
